XML 18 R8.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Supplemental disclosures of non-cash investing and financing activities              
Common stock issued through the dividend reinvestment plan (in shares)         1,891 1,703  
Common stock issued through the dividend reinvestment plan         $ 341 $ 293  
Number of shares withheld to satisfy employees' tax withholding and other liabilities (in shares)         92,333 62,215  
Shares withheld to satisfy employees' tax withholding and other liabilities         $ 16,460 $ 10,509  
Stock issued during period, value, share-based compensation, forfeited         506 108  
Dividends declared but not paid $ 244,082       244,082   $ 238,072
Gain on cash flow hedges 4,499 $ 7,339 $ 8,826 $ (340) 11,838 8,486  
Increase in derivative assets           8,486  
Cash flow hedge losses reclassified to earnings 69 $ (146) (354) $ (354) $ (77) (708)  
Cash flow hedge losses reclassified to earnings           $ 708  
Deferred Compensation, Share-based Payments [Member] | Non employee director              
Supplemental disclosures of non-cash investing and financing activities              
Equity instruments granted (in shares)         12,290    
Fair value of shares issued         $ 1,972    
Restricted Stock and Common Stock Converted from Performance Shares              
Supplemental disclosures of non-cash investing and financing activities              
Equity instruments granted (in shares)         248,420 152,708  
Performance Shares              
Supplemental disclosures of non-cash investing and financing activities              
Equity instruments granted (in shares)         87,748    
Converted to restricted stock (in shares)         146,725 60,016  
Restricted stock              
Supplemental disclosures of non-cash investing and financing activities              
Equity instruments granted (in shares)         101,695 92,692  
Fair value of shares issued         $ 17,505 $ 16,472  
Stock issued during period, shares, share-based compensation, forfeited (in shares)         2,702 566  
Common stock              
Supplemental disclosures of non-cash investing and financing activities              
Dividends declared but not paid $ 242,576   $ 235,206   $ 242,576 $ 235,206